We are pleased to share with you some exciting news about our recent feature on DirectorsTalk, where Gervais Williams provides insights into the impact of the Spring budget on investing and highlights several companies, including Celadon Pharmaceuticals Plc.

Gervais offers a comprehensive analysis of the budget’s implications for the UK equity markets and investors, highlighting noteworthy aspects that stood out to him. We are thrilled to have been recognised as a company to watch.